38 /100
MEDIUM RISK
Score updated May 30, 2026

STRO — Sutro Biopharma, Inc. Dilution Risk Tracker

Track STRO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track STRO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
📉 Score Deterioration 40%
• Score rose 17 points recently (worsening)
🔔 Track STRO — Get forecast alerts →

💹 Market Data

Market Cap$484.35M
Shares Outstanding16.57M
Float10.30M
Cash$141.43M
Debt$15.67M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 99.2% shares (2025Q4 vs prior)
10 institutional holders · 426.1K shares
#1 Merck & Co., Inc. 272.4K shares
#2 BANK OF AMERICA CORP /DE/ 119.4K shares
#3 AJU IB Investment Co., Ltd. 17.5K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest1.19M
Days to Cover5.6
% of Float11.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2018
xbrl XBRL CONVERTIBLE Dec 31, 2018
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track STRO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking STRO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for STRO
📊 STRO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 STRO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.